Zafrens is a drug discovery company that specializes in a high-throughput, high-resolution Z-Screen™ platform for analyzing CRISPR, CAR-T, mRNA libraries, and molecular heterogeneity, aiming to develop RNA-modulatory small molecules and TCR libraries for cancer treatment and seeking partnerships to expand its technology's applications.